147 related articles for article (PubMed ID: 19568715)
21. Post-marketing Re-evaluation of Tongxiening Granules () in Treatment of Diarrhea-Predominant Irritable Bowel Syndrome: A Multi-center, Randomized, Double-Blind, Double-Dummy and Positive Control Trial.
Tang XD; Zhang SS; Hou XH; Li ZH; Chen SN; Feng PM; Yang XN; Li HZ; Wu JQ; Xia PJ; Yang XJ; Zhou HJ; Wang HY; Ai YW; Li K
Chin J Integr Med; 2019 Dec; 25(12):887-894. PubMed ID: 31292845
[TBL] [Abstract][Full Text] [Related]
22. Eluxadoline benefits patients with irritable bowel syndrome with diarrhea in a phase 2 study.
Dove LS; Lembo A; Randall CW; Fogel R; Andrae D; Davenport JM; McIntyre G; Almenoff JS; Covington PS
Gastroenterology; 2013 Aug; 145(2):329-38.e1. PubMed ID: 23583433
[TBL] [Abstract][Full Text] [Related]
23. [Associations of sigmoid colon mucosal mast cells with bowel symptoms and psychological status in patients with irritable bowel syndrome with diarrhea].
Xu D; Chen W; Zhou WX; Wang CD; Fei GJ; Zhu LM; Xin HW; Zhong DR; Sun G; Fang XC
Zhonghua Yi Xue Za Zhi; 2016 Aug; 96(30):2398-403. PubMed ID: 27545031
[TBL] [Abstract][Full Text] [Related]
24. A dose-ranging, phase II study of the efficacy and safety of alosetron in men with diarrhea-predominant IBS.
Chang L; Ameen VZ; Dukes GE; McSorley DJ; Carter EG; Mayer EA
Am J Gastroenterol; 2005 Jan; 100(1):115-23. PubMed ID: 15654790
[TBL] [Abstract][Full Text] [Related]
25. Treating Chronic Abdominal Pain in Patients with Chronic Abdominal Pain and/or Irritable Bowel Syndrome.
Stemboroski L; Schey R
Gastroenterol Clin North Am; 2020 Sep; 49(3):607-621. PubMed ID: 32718573
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of Qinghua Zhixie Decoction against diarrhea-predominate irritable bowel syndrome: A protocol for a randomized controlled trial.
Ji L; Zhao X; Zhang Y; Zhao P; Gong R; Li F; Huang H
Medicine (Baltimore); 2022 Mar; 101(9):e28895. PubMed ID: 35244043
[TBL] [Abstract][Full Text] [Related]
27. [Diarrhea-predominant irritable bowel syndrome of spleen deficiency and damp excess treated with fire needling therapy with filiform needle and acupoint application therapy: a randomized controlled trial].
Shi H; Niu Y; Huang Q; Yang ZM; Yang L
Zhongguo Zhen Jiu; 2021 Sep; 41(9):984-90. PubMed ID: 34491647
[TBL] [Abstract][Full Text] [Related]
28. Repeat Treatment With Rifaximin Is Safe and Effective in Patients With Diarrhea-Predominant Irritable Bowel Syndrome.
Lembo A; Pimentel M; Rao SS; Schoenfeld P; Cash B; Weinstock LB; Paterson C; Bortey E; Forbes WP
Gastroenterology; 2016 Dec; 151(6):1113-1121. PubMed ID: 27528177
[TBL] [Abstract][Full Text] [Related]
29. Update on the Management of Diarrhea-Predominant Irritable Bowel Syndrome: Focus on Rifaximin and Eluxadoline.
Rivkin A; Rybalov S
Pharmacotherapy; 2016 Mar; 36(3):300-16. PubMed ID: 26971716
[TBL] [Abstract][Full Text] [Related]
30. [A multi-center randomized controlled trial on treatment of diarrhea-predominant irritable bowel syndrome by Chinese medicine syndrome-differentiation therapy].
Zhang SS; Wang HB; Li ZH
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Jan; 30(1):9-12. PubMed ID: 20353023
[TBL] [Abstract][Full Text] [Related]
31. Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome.
Park JH; Rhee PL; Kim HS; Lee JH; Kim YH; Kim JJ; Rhee JC
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):71-8. PubMed ID: 16706815
[TBL] [Abstract][Full Text] [Related]
32. Eluxadoline for Irritable Bowel Syndrome with Diarrhea.
Lembo AJ; Lacy BE; Zuckerman MJ; Schey R; Dove LS; Andrae DA; Davenport JM; McIntyre G; Lopez R; Turner L; Covington PS
N Engl J Med; 2016 Jan; 374(3):242-53. PubMed ID: 26789872
[TBL] [Abstract][Full Text] [Related]
33. Effects of two natural medicine formulations on irritable bowel syndrome symptoms: a pilot study.
Hawrelak JA; Myers SP
J Altern Complement Med; 2010 Oct; 16(10):1065-71. PubMed ID: 20954962
[TBL] [Abstract][Full Text] [Related]
34. [Effects of Changjishu soft elastic capsule in treatment of diarrhea-predominant irritable bowel patients with liver-qi stagnation and spleen deficiency syndrome: a randomized double-blinded controlled trial].
Gao WY; Lin YF; Chen SQ; Lu YP; Yang Z; Gong Y; Liu Y; Wang LX; Wang CH
Zhong Xi Yi Jie He Xue Bao; 2009 Mar; 7(3):212-7. PubMed ID: 19284948
[TBL] [Abstract][Full Text] [Related]
35. Optimal dose of ramosetron in female patients with irritable bowel syndrome with diarrhea: A randomized, placebo-controlled phase II study.
Fukudo S; Matsueda K; Haruma K; Ida M; Hayase H; Akiho H; Nakashima Y; Hongo M
Neurogastroenterol Motil; 2017 Jun; 29(6):. PubMed ID: 28205278
[TBL] [Abstract][Full Text] [Related]
36. Prostaglandin E
Grabauskas G; Wu X; Gao J; Li JY; Turgeon DK; Owyang C
Gastroenterology; 2020 Jun; 158(8):2195-2207.e6. PubMed ID: 32084424
[TBL] [Abstract][Full Text] [Related]
37. Effect of Shugan Jianpi Recipe Combined with Cross Moxibustion on Biochemical Examination Indexes and Total Score of TCM Symptoms in Patients with Spleen-Stomach Damp-Heat Diarrhea Irritable Bowel Syndrome.
Liu D; Ruan M; Tong C; Huang R
Comput Math Methods Med; 2022; 2022():8286146. PubMed ID: 35502412
[TBL] [Abstract][Full Text] [Related]
38. Are personalized tongxie formula based on diagnostic analyses more effective in reducing IBS symptoms?-A randomized controlled trial.
Wang Y; Fan H; Qi X; Lai Y; Yan Z; Li B; Tang M; Huang D; Li Z; Chen H; Zhu Q; Luo C; Chen X; Fen J; Jiang Z; Zheng L; Liu X; Tang Q; Zuo D; Ye J; Yang Y; Huang H; Tang Z; Lu W; Xiao J;
Complement Ther Med; 2018 Oct; 40():95-105. PubMed ID: 30219477
[TBL] [Abstract][Full Text] [Related]
39. Rifaximin therapy for patients with irritable bowel syndrome without constipation.
Pimentel M; Lembo A; Chey WD; Zakko S; Ringel Y; Yu J; Mareya SM; Shaw AL; Bortey E; Forbes WP;
N Engl J Med; 2011 Jan; 364(1):22-32. PubMed ID: 21208106
[TBL] [Abstract][Full Text] [Related]
40. [Randomized controlled clinical study on effect of Chinese compound changjitai in treating diarrheic irritable bowel syndrome].
Shen Y; Cai G; Sun X
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2003 Nov; 23(11):823-5. PubMed ID: 14666762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]